Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             123 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2011
21 S2 p. S177-S179
3 p.
artikel
2 Keyword Index 2011
21 S2 p. S181-S182
2 p.
artikel
3 K.2 Glutamatergic systems and brain diseases Bespalov, A.
2011
21 S2 p. S101-
1 p.
artikel
4 P.7.003 Acute hypoxia, modelled in early pregnancy, causes transgenerational effects on child neurodevelopment Graf, A.V.
2011
21 S2 p. S170-
1 p.
artikel
5 P.4.009 Afobazol as inhibitor of NRH: quinone reductase 2 enzyme Kadnikov, I.
2011
21 S2 p. S149-S150
2 p.
artikel
6 P.4.014 Afobazol differently modulates monoamine levels in the brain structures of C57BL/6 and BALB/C mice after serotonin depletion induced by PCPA Klodt, P.
2011
21 S2 p. S152-
1 p.
artikel
7 P.8.005 Alexithymia in oncological patients: the role of hemoglobin, malignancy type and tumor staging Messina, A.
2011
21 S2 p. S174-S175
2 p.
artikel
8 P.1.029 Alterations in somatostatin binding sites in brains of rats subjected to chronic mild stress Kusmider, M.
2011
21 S2 p. S132-
1 p.
artikel
9 P.4.011 Analogues of cyclo-L-prolylglycine and their anxiolytic, nootropic and antihypoxic activity Koliasnikova, K.N.
2011
21 S2 p. S150-S151
2 p.
artikel
10 P.2.009 Analysis of CYP2D6*4 and 5-HTTLPR polymorphisms in a sample of North Bulgarian outpatients with depression and antidepressant treatment Pendicheva, D.
2011
21 S2 p. S141-
1 p.
artikel
11 P.6.012 Analysis of the impact of different forms of naltrexone on the syndrome of anhedonia and depression among heroin addicts Tiurina, A.
2011
21 S2 p. S166-
1 p.
artikel
12 P.8.004 A novel active small mimetic of brain-derived neurotrophic factor: bis-(N-monosuccinyl-seryl-lysine) hexamethylenediamide Tarasiuk, A.V.
2011
21 S2 p. S174-
1 p.
artikel
13 P.4.017 Antihypoxic and enzyme inhibitory activity of the new anxiolytic drug afobazol Koliasnikova, K.N.
2011
21 S2 p. S153-S154
2 p.
artikel
14 P.1.035 Antinociceptive, anti-inflammatory and gastroprotective effects of CysLT1 receptor blockers in rats Marusov, I.
2011
21 S2 p. S135-S136
2 p.
artikel
15 P.1.016 Antiserotoninergic and cerebrovascular effects of combination of tropoxin and mexidol Gorbunov, A.
2011
21 S2 p. S124-S125
2 p.
artikel
16 P.4.002 Anxiogenic or anxiolytic effects of nociception analogue are dose-dependent and sex-specific Ivanova, E.
2011
21 S2 p. S145-S146
2 p.
artikel
17 P.4.005 Anxiolytic profile of 5-HT3-antagonist RU 1204 versus tropisetron and diazepam Yakovlev, D.
2011
21 S2 p. S147-
1 p.
artikel
18 P.2.007 Assessment of memory and learning of lithium-treated euthymic bipolar patients Suwalska, A.
2011
21 S2 p. S140-
1 p.
artikel
19 P.1.013 Association between suicidal behaviour and genes of serotonergic system in affective disorders Pawlak, J.
2011
21 S2 p. S123-
1 p.
artikel
20 P.1.025 BDNF gene and personality traits in anorexia nervosa patients and healthy subjects Dmitrzak-Weglarz, M.
2011
21 S2 p. S129-S130
2 p.
artikel
21 P.7.005 BDNF gene polymorphism and Wisconsin Card Sorting Test in children with ADHD and healthy controls Slopien, A.
2011
21 S2 p. S171-S172
2 p.
artikel
22 P.5.009 Behavioural and biochemical effects of a novel dipeptide mimetic of nerve growth factor on a model of incomplete global ischemia in rats Povarnina, P.
2011
21 S2 p. S158-S159
2 p.
artikel
23 P.1.011 Behavioural characterisation of magnesium effects in rats Samardzic, J.
2011
21 S2 p. S122-
1 p.
artikel
24 P.1.015 Cerebrovascular effects of mexidol in conditions of separate and combined vascular pathology of brain and heart Gnezdilova, A.
2011
21 S2 p. S124-
1 p.
artikel
25 P.1.031 Changes in [3H]domperidone binding in rat brains after chronic mild stress Zurawek, D.
2011
21 S2 p. S133-
1 p.
artikel
26 P.1.027 Changes of gene expression in the pituitary reflect different stress responses in rats exposed to chronic stress Gaska, M.
2011
21 S2 p. S131-
1 p.
artikel
27 P.1.017 Chronic stress-induced impairment of memory in rats can be prevented by parallel administration of cod liver oil Braszko, J.
2011
21 S2 p. S125-
1 p.
artikel
28 P.1.023 Circulatory shock as the physiological basis of delirium tremens Galankin, T.
2011
21 S2 p. S128-S129
2 p.
artikel
29 P.3.002 Clebopride, an antagonist of dopamine type 2 receptors, in low doses improves learning with positive reinforcement Malyshev, A.V.
2011
21 S2 p. S142-S143
2 p.
artikel
30 P.7.004 Cognitive and psychological problems in patients with cerebral palsy and epilepsy Ignjatovic, P.
2011
21 S2 p. S171-
1 p.
artikel
31 P.2.003 Cognitive functioning in depressed patients treated with specific serotonin reuptake inhibitors and tricyclic antidepressants Pânzaru, C.
2011
21 S2 p. S137-S138
2 p.
artikel
32 P.7.001 Cognitive functions at 6 years of age after fetal exposure to antiepileptic drugs used in mothers with juvenile myoclonic epilepsy Jovic, N.
2011
21 S2 p. S169-
1 p.
artikel
33 P.6.002 Comparative characteristics of neurocognitive functioning in patients with different types of abuse Bushara, N.
2011
21 S2 p. S160-S161
2 p.
artikel
34 P.4.016 Comparative study of afobazol and diazepam behavioural effects in pentylenetetrazole-induced anxiety model in Wistar rats Volkova, A.
2011
21 S2 p. S153-
1 p.
artikel
35 P.6.005 Comparative study of the abuse potential of the kappa-opoioid agonist RU-1203 Grechko, O.
2011
21 S2 p. S162-S163
2 p.
artikel
36 P.1.018 Comparative study of the effects of afobazol and its main metabolite on learning and memory processes in a model of hemorrhagic stroke Krayneva, V.
2011
21 S2 p. S126-
1 p.
artikel
37 P.4.010 Considerably different mechanisms underlie the effects of the ACTH(4–10) analogue semax on stress-induced analgesia and stress-induced behaviour Manchenko, D.
2011
21 S2 p. S150-
1 p.
artikel
38 P.5.001 Difference in lesions induced by unilateral administration of 6-hydroxydopamine into the left and right substantia nigra pars compacta Ivanova, E.
2011
21 S2 p. S154-
1 p.
artikel
39 P.1.021 Different influence of dopaminergic system genes on working memory in healthy subjects Tomaszewska, M.
2011
21 S2 p. S127-S128
2 p.
artikel
40 P.3.005 Dilept - a novel type of antipsychotic based on neurotensin Ostrovskaya, R.U.
2011
21 S2 p. S144-S145
2 p.
artikel
41 P.4.004 Dipeptide anxiolytic GB-115: new receptor targets Kolik, L.
2011
21 S2 p. S146-S147
2 p.
artikel
42 P.8.006 Effectiveness of idebenone therapy in Leber's hereditary optic neuropathy Jancic, J.
2011
21 S2 p. S175-
1 p.
artikel
43 P.1.024 Effect of chirality on the analgesic action of the C-terminal dermorphin fragment Tyr-Pro-Ser-NH2 Guzevatykh, L.
2011
21 S2 p. S129-
1 p.
artikel
44 P.1.005 Effect of estradiol on pain behaviour in two models of chronic pain in rats Shekunova, E.
2011
21 S2 p. S119-
1 p.
artikel
45 P.6.007 Effect of L-glutamine and its dipeptides on the level of voluntary alcohol consumption in rats Pronko, P.S.
2011
21 S2 p. S163-S164
2 p.
artikel
46 P.6.014 Effect of mitochondrial antioxidant SKQ-1 on the behaviour of albino rats after acute ethanol intoxication Efimova, E.V.
2011
21 S2 p. S167-S168
2 p.
artikel
47 P.5.007 Effect of nanosomic erythropoietin in rats with intracerebral post-traumatic haematoma (hemorrhagic stroke) Solev, I.N.
2011
21 S2 p. S157-S158
2 p.
artikel
48 P.4.008 Effect of opiate system blockade on the anxiolytic effects of a benzodiazepine tranquillizer in inbred mice with active versus passive stress response Nadorova, A.V.
2011
21 S2 p. S149-
1 p.
artikel
49 P.4.013 Effect of peripheral administration of peptide ligands of opioid receptors on anxiety and locomotor activity in rats Nazarova, G.A.
2011
21 S2 p. S151-S152
2 p.
artikel
50 P.5.005 Effects of a novel neuroprotective calcium salt of N-(5-hydroxy-nicotinoyl)-L-glutamate in a model of Alzheimer's disease and in aging rodents Kiselev, A.
2011
21 S2 p. S156-
1 p.
artikel
51 P.8.003 Effects of chronic maternal deprivation in white rats and their correction by administration of the ACTH(4–10) analogue semax Sebentsova, E.A.
2011
21 S2 p. S173-S174
2 p.
artikel
52 P.1.022 Effects of enoxifol on central neurotransmission Goryagin, I.I.
2011
21 S2 p. S128-
1 p.
artikel
53 P.1.009 Effects of the novel antiparkinsonian drug hemantane on brain bioelectric activity in mice with parkinsonian syndrome Kapitsa, I.
2011
21 S2 p. S120-S121
2 p.
artikel
54 P.7.002 Elevated level of homocysteine in children and adolescents with psychotic and mood disorders Kevere, L.
2011
21 S2 p. S169-S170
2 p.
artikel
55 P.1.033 Experimental pharmacokinetics and metabolism of a new potential antipsychotic Boyko, S.S.
2011
21 S2 p. S134-S135
2 p.
artikel
56 P.3.004 Family-based association study of glycogen synthase kinase 3 (GSK3)-beta gene polymorphism in schizophrenia Skibinska, M.
2011
21 S2 p. S143-S144
2 p.
artikel
57 P.1.010 Gender-dependent effects of prolonged maternal deprivation and their correction by an analogue of adrenocorticotropic hormone (4–10) Volodina, M.A.
2011
21 S2 p. S121-
1 p.
artikel
58 P.8.002 Hydrolysis of 1-methyl-5-phenyl-3-acetoxy-7-bromo-1,2-dihydro-3H-1,4-benzodiazepine-2-one with the help of pig liver microsomes Shesterenko, E.A.
2011
21 S2 p. S172-S173
2 p.
artikel
59 P.2.005 Individual sensitivity of white rats to selective stimulation of neurotransmitter systems Frolova, G.
2011
21 S2 p. S139-
1 p.
artikel
60 P.1.020 Influence of melatonin on blood flow in cerebral cortex under conditions of global transient ischemia Maslennikov, D.
2011
21 S2 p. S127-
1 p.
artikel
61 P.1.003 Influence of naloxone administration on the maternal behaviour in sensitised rat dams Tanaeva, K.K.
2011
21 S2 p. S118-
1 p.
artikel
62 P.6.010 Influence of naltrexone and acamprosate on the sensitivity of cerebral cortical neurons to ethanol. Electrophysiological study Kozhechkin, S.N.
2011
21 S2 p. S165-
1 p.
artikel
63 P.6.009 Influence of olfactory bulbectomy on extinction and drug-seeking behaviour in rats exposed to intravenous cocaine self-administration Filip, M.
2011
21 S2 p. S164-S165
2 p.
artikel
64 P.4.001 Influence of single and chronic intranasal injections of the arginine-vasopressin fragment Ac-D-MPRG on the ontogeny of the behavioural reactions in white rats Voskresenskaya, O.
2011
21 S2 p. S145-
1 p.
artikel
65 P.8.001 Investigation of patients' satisfaction with treatment in a mental hospital Semenova, N.V.
2011
21 S2 p. S172-
1 p.
artikel
66 P.6.016 Is use of caffeinated energy drinks associated with higher levels of tobacco, alcohol and other drug use in American students? Hull, L.
2011
21 S2 p. S168-S169
2 p.
artikel
67 P.6.001 Long-term effects of pre-mating morphine exposure on maternal behaviour differ from the effects of acute morphine administration Dobryakova, Y.
2011
21 S2 p. S160-
1 p.
artikel
68 P.1.026 Low dose nicotine improves 6-OHDA-induced impairment of memory, oxidative stress and food reward in nucleus accumbens Ciobica, A.
2011
21 S2 p. S130-S131
2 p.
artikel
69 P.1.002 Memory-stimulating effect of dehydroepiandrosterone: involvement of dopaminergic receptor systems Fedotova, J.
2011
21 S2 p. S117-S118
2 p.
artikel
70 P.6.004 Modulation of rewarding effects of psychotropic drugs by GABA and dopamine mechanisms from the bed nucleus of the stria terminalis Shabanov, P.
2011
21 S2 p. S161-S162
2 p.
artikel
71 P.6.006 Molecular genetic markers of the duration of therapeutic remission in patients with alcohol dependence Kibitov, A.
2011
21 S2 p. S163-
1 p.
artikel
72 P.5.002 Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients Berkovich, R.
2011
21 S2 p. S154-S155
2 p.
artikel
73 P.6.008 Neuropeptide in treatment of alcoholism: effect on psychological functions and lymphocyte apoptosis Ivanova, S.
2011
21 S2 p. S164-
1 p.
artikel
74 P.1.036 Neurophysiological markers of cognitive disorders and 1H-magnetic resonance spectroscopy in dorsolateral prefrontal cortex of first-episode patients Lebedeva, I.
2011
21 S2 p. S136-
1 p.
artikel
75 P.5.004 Neuroprotective effect of proline-containing dipeptide, noopept on PC12 neuronal cells Salimgareeva, M.K.
2011
21 S2 p. S155-S156
2 p.
artikel
76 P.1.019 Neuroprotective properties of a low molecular weight dipeptide analogue of BDNF -GSB-106 in cell culture Logvinov, I.O.
2011
21 S2 p. S126-S127
2 p.
artikel
77 P.6.015 New cholecyctokinin-4 retroanalog and dipeptide analog of neurotensin as opiate dependence correctors: an experimental study Konstantinopolsky, M.A.
2011
21 S2 p. S168-
1 p.
artikel
78 P.3.003 New standardised clinico-functional criteria for therapeutic remission in schizophrenia: description and validation Potapov, A.
2011
21 S2 p. S143-
1 p.
artikel
79 P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia Loonen, A.J.M.
2011
21 S2 p. S142-
1 p.
artikel
80 P.1.006 No association between promoter polymorphism of the MAOA gene and Alzheimer's disease Juhasz, A.
2011
21 S2 p. S119-S120
2 p.
artikel
81 P.5.003 Pharmacokinetics of himantane in rabbits Litvin, E.A.
2011
21 S2 p. S155-
1 p.
artikel
82 P.6.011 Pharmacological profile of the nicotinic receptor partial agonist cytisine: effects on maintenance and relapse to nicotine seeking Radchenko, E.
2011
21 S2 p. S165-S166
2 p.
artikel
83 P.5.006 Piracetam treatment and cognitive performance of patients with mild cognitive impairment Borkowska, A.
2011
21 S2 p. S157-
1 p.
artikel
84 P.1.004 PLA2G4A and PTGS2 gene polymorphisms in schizophrenia Feher, A.
2011
21 S2 p. S118-S119
2 p.
artikel
85 P.6.013 Polysubstance use among HIV-infected drinkers in Russia Blokhina, E.
2011
21 S2 p. S167-
1 p.
artikel
86 P.5.008 Prevalence of dementia in St. Petersburg and Leningrad Region (Russian Federation), 2000–2004 Sluchevskaya, S.
2011
21 S2 p. S158-
1 p.
artikel
87 P.1.007 Protective effect of the antiparkinsonian drug hemantane in an MPTP model using C57BL/6 mice Nepoklonov, A.
2011
21 S2 p. S120-
1 p.
artikel
88 P.6.003 Psychiatric co-morbidity and suicidality among methamphetamine dependent patients who seek treatment in Malaysia Hatim, A.
2011
21 S2 p. S161-
1 p.
artikel
89 P.2.004 Psychopharmacological treatment may affect the efficacy of antiviral treatment in patients with chronic hepatitis C Drozdz, W.
2011
21 S2 p. S138-S139
2 p.
artikel
90 P.1.034 Self reported traffic violations and driving errors are associated with markers of the serotonin system Eensoo, D.
2011
21 S2 p. S135-
1 p.
artikel
91 P.1.028 Serum levels of somatostatin-28 and its binding sites in medial habenular nucleus differentiate rats responding and non responding to chronic mild stress Faron-Górecka, A.
2011
21 S2 p. S131-S132
2 p.
artikel
92 P.4.012 Study of the structure-anxiolytic activity relationship among new pyrrolo[1,2-a]pyrazine derivatives Mokrov, G.V.
2011
21 S2 p. S151-
1 p.
artikel
93 P.5.010 The behavioural and neurochemical effects of NGF dipeptide fragment GK-2 in MPTP-lesioned C57BL mice Ponomarev, A.V.
2011
21 S2 p. S159-
1 p.
artikel
94 P.4.006 The bioavailability of afobazol and compound M-11 in rats Bastrygin, D.V.
2011
21 S2 p. S147-S148
2 p.
artikel
95 P.8.007 The biotechnological production of potential neuroprotectants: oligo-3-hydroxybutyrates Bonartsev, A.P.
2011
21 S2 p. S175-S176
2 p.
artikel
96 P.4.007 The effect of changes in the brain opioid system activity on the adaptive behavior of BALB/c and C57BL/6 mice Nadorova, A.V.
2011
21 S2 p. S148-
1 p.
artikel
97 P.1.001 The effect of glutamate antibodies on the memory of rats with experimental ischemic damage to the prefrontal cortex Romanova, G.
2011
21 S2 p. S117-
1 p.
artikel
98 P.2.006 The effects of ZP-122 on prolyl endopeptidase activity in the brain structures of C57BL/6 and Balb/C mice after Porsolt test Shipilov, I.A.
2011
21 S2 p. S139-S140
2 p.
artikel
99 P.1.032 The impact of psychological stress factors and cortisol on prenatal anxiety and depression Salacz, P.
2011
21 S2 p. S134-
1 p.
artikel
100 P.4.015 The interlinear effects of the combined injection of afobazol and selective antagonists of serotonin (5-HT) receptors: a behavioural study Narkevich, V.B.
2011
21 S2 p. S152-S153
2 p.
artikel
101 P.1.012 The main proinflammatory cytokines in neuroimmune interactions Kovalenko, L.
2011
21 S2 p. S122-S123
2 p.
artikel
102 P.2.001 The presence and clinical implications of comorbid depressive disorder in women with epilepsy Todorova, K.
2011
21 S2 p. S136-S137
2 p.
artikel
103 P.4.003 Thermotropic liquid crystal - potential enhancer of transdermal delivery of 1.4-benzodiazepines Kravchenko, I.A.
2011
21 S2 p. S146-
1 p.
artikel
104 P.1.030 The role of environmental effects in the serotonergic and adrenergic mediated neuro-endocrine-behavioural response by Wistar rats Galfi, M.
2011
21 S2 p. S132-S133
2 p.
artikel
105 P.2.008 Treatment of bipolar disorder with somatic comorbidities - an overview of drug-drug interactions Marinescu, V.
2011
21 S2 p. S140-S141
2 p.
artikel
106 P.2.002 Trends in depression diagnoses and antidepressants consumption in Lithuania in 2004–2009 Kavaliauskiene, L.
2011
21 S2 p. S137-
1 p.
artikel
107 P.5.011 Unseen face of polypharmacy in Alzheimer's disease - a focus on drug-drug interactions Vrabie, M.
2011
21 S2 p. S159-S160
2 p.
artikel
108 P.1.014 Vasopressin 1b receptor polymorphism is associated with bipolar disorder Szczepankiewicz, A.
2011
21 S2 p. S123-S124
2 p.
artikel
109 S.4.02 ADHD and bipolar disorder in children and adolescents Moreno, C.
2011
21 S2 p. S114-S115
2 p.
artikel
110 S.2.04 Adherence to treatment in bipolar disorders Gonzalez-Pinto, A.
2011
21 S2 p. S108-S109
2 p.
artikel
111 S.3.01 Biomarkers for anxiety disorders: proteomic and systems biology approaches Turck, C.W.
2011
21 S2 p. S110-S111
2 p.
artikel
112 S.3.02 Depression in females: difficulties in modelling and pharmacological studies Avgustinovich, D.
2011
21 S2 p. S111-S112
2 p.
artikel
113 S.1.04 How neuroadaptation may preclude effective pharmacotherapy for cocaine dependence Noble, F.
2011
21 S2 p. S106-
1 p.
artikel
114 S.3.03 Inter-individual differences in impulsivity and underlying neurobiology Dalley, J.W.
2011
21 S2 p. S112-S113
2 p.
artikel
115 S.3.05 Low positive affect, anxiety and depression Harro, J.
2011
21 S2 p. S113-S114
2 p.
artikel
116 S.1.02 Naltrexone for opiate dependence: oral, implantable, and injectable Krupitsky, E.
2011
21 S2 p. S104-S105
2 p.
artikel
117 S.1.03 Nicotine-opioid interactions: in vitro and in vivo studies Tuominen, R.K.
2011
21 S2 p. S105-S106
2 p.
artikel
118 S.3.04 Phenotype of stress response and effects of psychotropic drugs Seredenin, S.
2011
21 S2 p. S113-
1 p.
artikel
119 S.2.05 Psychoeducation and shared decision making as a way to reduce non-compliance in mental disorders Leucht, S.
2011
21 S2 p. S109-S110
2 p.
artikel
120 S.1.05 Psychopharmacological strategy in the treatment of drug dependence Vinnikova, M.
2011
21 S2 p. S106-S107
2 p.
artikel
121 S.2.03 Reasons for schizophrenia patients to refuse long-term use of antipsychotics Avedisova, A.
2011
21 S2 p. S108-
1 p.
artikel
122 S.4.05 Suicide prevention in patients with mood disorder Rihmer, Z.
2011
21 S2 p. S115-S116
2 p.
artikel
123 S.1.01 The opioid system and protracted abstinence to drugs of abuse Befort, K.
2011
21 S2 p. S103-S104
2 p.
artikel
                             123 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland